Compounds > angiotensin ii
Page last updated: 2024-08-22

angiotensin ii and fluorobenzenes

angiotensin ii has been researched along with fluorobenzenes in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's6 (54.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Böhm, M; Custodis, F; Eberl, M; Kilter, H; Laufs, U1
Andresen, BT; Cooper, SA; DeMarco, VG; Ferrario, C; Habibi, J; Hayden, MR; Karuparthi, PR; Nistala, R; Rehmer, N; Sowers, JR; Wei, Y; Whaley-Connell, A1
Buikema, H; de Smet, BJ; Groenewegen, HC; Roks, AJ; van der Harst, P; van Gilst, WH; Zijlstra, F1
Fiebeler, A; Haller, H; Luft, FC; Menne, J; Mervaala, EM; Muller, DN; Park, JK1
Kang, BY; Mehta, JL1
Bi, H; Chen, WA; Daugherty, A; Hong, B; Luo, Y; Wang, JA; Wang, Y; Xie, X; Zhang, S1
Chen, ZY; Huang, Y; Lau, CW; Lee, VW; Liu, LM; Lu, Y; Tian, XY; Wong, WT; Xu, A; Yao, X1
Ferrannini, E; Madec, S; Rossi, C; Salvati, A; Santini, E; Solini, A1
Antonioli, L; Aydinoglu, F; Bernardini, N; Blandizzi, C; Colucci, R; Duranti, E; Fornai, M; Ippolito, C; Rugani, I; Segnani, C; Taddei, S; Virdis, A1
Cai, S; Chu, X; Li, Y; Liu, X; Sun, T; Wang, Q; Xu, Q; Zhou, J1
Collado, A; Escudero, P; Gonzalez-Navarro, H; Hermenegildo, C; Martinez de Marañón, A; Peiró, C; Piqueras, L; Sanz, MJ1

Other Studies

11 other study(ies) available for angiotensin ii and fluorobenzenes

ArticleYear
Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.
    Cardiovascular research, 2006, Jul-15, Volume: 71, Issue:2

    Topics: Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cells, Cultured; Fluorobenzenes; Free Radicals; Guanine Nucleotide Dissociation Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoprecipitation; Leucine; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Myocardium; NADPH Oxidases; Protein Binding; Pyrimidines; rac1 GTP-Binding Protein; rho Guanine Nucleotide Dissociation Inhibitor alpha; rho-Specific Guanine Nucleotide Dissociation Inhibitors; RNA Interference; Rosuvastatin Calcium; Sulfonamides; Superoxides

2006
Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:2

    Topics: Albuminuria; Angiotensin II; Animals; Animals, Genetically Modified; Biomarkers; Blood Pressure; Cell Line, Transformed; Enzyme Activation; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoenzymes; Kidney Cortex; Kidney Glomerulus; Male; Mice; Microscopy, Electron; NADPH Oxidases; Oxidative Stress; Podocytes; Pyrimidines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Renin; Rosuvastatin Calcium; Sulfonamides

2008
Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat.
    Coronary artery disease, 2008, Volume: 19, Issue:1

    Topics: Angiotensin II; Animals; Fluorobenzenes; Graft Occlusion, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperplasia; Male; Pyrimidines; Random Allocation; Rats; Rats, Wistar; Rosuvastatin Calcium; Stents; Sulfonamides; Tunica Intima

2008
Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
    Journal of hypertension, 2009, Volume: 27, Issue:3

    Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Collagen Type IV; Disease Models, Animal; Dose-Response Relationship, Drug; Fibronectins; Fluorescent Antibody Technique, Indirect; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Immunohistochemistry; Inflammation; Intercellular Adhesion Molecule-1; Kidney; Kidney Cortex; Kidney Medulla; Male; Monocytes; Necrosis; Neutrophil Infiltration; Nitric Oxide Synthase Type II; Pyrimidines; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Rosuvastatin Calcium; Sulfonamides

2009
Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
    Journal of cardiovascular pharmacology and therapeutics, 2009, Volume: 14, Issue:4

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Culture Techniques; Cell Size; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Losartan; Mice; Myocytes, Cardiac; NADP; NF-kappa B p50 Subunit; Pyrimidines; Receptor, Angiotensin, Type 1; RNA, Messenger; Rosuvastatin Calcium; Scavenger Receptors, Class E; Sulfonamides; Transfection; Up-Regulation

2009
Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms.
    Atherosclerosis, 2011, Volume: 217, Issue:1

    Topics: Angiotensin II; Animal Feed; Animals; Anti-Inflammatory Agents; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Atorvastatin; Blood Pressure; Fluorobenzenes; Gene Expression Regulation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Mice; Mice, Inbred C57BL; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides

2011
Rosuvastatin improves endothelial function in db/db mice: role of angiotensin II type 1 receptors and oxidative stress.
    British journal of pharmacology, 2011, Volume: 164, Issue:2b

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Endothelium, Vascular; Fluorobenzenes; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; NADPH Oxidases; Nitrogen Oxides; Oxidative Stress; Phenylephrine; Pyrimidines; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renal Artery; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Vasodilation

2011
Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
    Journal of hypertension, 2011, Volume: 29, Issue:10

    Topics: Angiotensin II; Cells, Cultured; Extracellular Matrix; Fatty Acids, Nonesterified; Fibrosis; Fluorobenzenes; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mesangial Cells; Metalloproteases; Pyrimidines; RNA, Small Interfering; Rosuvastatin Calcium; Sulfonamides; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta

2011
Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1.
    British journal of pharmacology, 2013, Volume: 169, Issue:3

    Topics: Angiotensin II; Animals; Atherosclerosis; Cyclooxygenase 1; Disease Models, Animal; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Extracellular Matrix; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mechanical Phenomena; Membrane Proteins; Mesenteric Arteries; NADPH Oxidase 4; NADPH Oxidases; Phosphorylation; Protein Processing, Post-Translational; Pyrimidines; Rats; Rats, Sprague-Dawley; Rosuvastatin Calcium; Sulfonamides; Vascular Resistance; Vasodilation

2013
Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
    European journal of pharmacology, 2014, Jan-15, Volume: 723

    Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; Cholesterol; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pyrimidines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Rosuvastatin Calcium; Scavenger Receptors, Class B; Sulfonamides; Triglycerides; Up-Regulation

2014
Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions.
    Antioxidants & redox signaling, 2015, Apr-10, Volume: 22, Issue:11

    Topics: Angiotensin II; Anticarcinogenic Agents; Arteries; Bexarotene; Cell Adhesion; Cell Line; Fluorobenzenes; Humans; Leukocytes, Mononuclear; Membrane Proteins; NADPH Oxidase 5; NADPH Oxidases; Nitric Oxide; Peroxisome Proliferator-Activated Receptors; Pyrimidines; Retinoid X Receptors; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Tetrahydronaphthalenes

2015